Skip to main content
SpringerLink
Log in

Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Results of circulating Ghrelin levels in hyper- or hypothyroidism are conflicting and only overt thyroid dysfunction has been evaluated. Aim: To evaluate in a large number of patients with thyroid disfunction whether: a) hyper- and hypothyroidism (clinical or subclinical) are associated with variations in both acylated (AG) and total Ghrelin (TG) concentrations, and b) correction of thyroid dysfunction is followed by variations in Ghrelin concentrations. Subjects and methods: Seventy-six hyperthyroids, 52 hypothyroids, 144 euthyroids with chronic autoimmune thyroiditis, and 109 euthyroid healthy controls were evaluated cross-sectionally and longitudinally. Results: TG and AG were significantly lower in hyperthyroids than in controls or hypothyroids; the latter 2 groups did not differ. TG was significantly lower in overt than in subclinical hyperthyroids. with a trend to a reduction also in AG levels. No differences were found between subclinical hyperthyroids and controls. After thionamide treatment, TG and AG levels in hyperthyroids did not differ from controls. L-thyroxine management of hypothyroidism was not associated with significant Ghrelin variations. Plasma Ghrelin was independent of either thyroid or gastric autoimmunity. Plasma TG was negatively correlated with serum free thyroid hormone levels in hyperthyroids but not in hypothyroids. Conclusions: Plasma Ghrelin concentrations are reduced in overt but not in subclinical hyperthyroidism and normalize after restoration of euthyroidism. Hypothyroidism is not accompanied by significant changes in circulating Ghrelin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–60.

    Article  CAS  PubMed  Google Scholar 

  2. Van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25: 426–57.

    Article  PubMed  Google Scholar 

  3. Seoane LM, Tovar S, Baldelli R, et al. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol 2000, 143: R7–9.

    Article  CAS  PubMed  Google Scholar 

  4. Hataya Y, Akamizu T, Takaya K, et al. A low dose of Ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001, 86: 4552–5.

    Article  CAS  PubMed  Google Scholar 

  5. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86: 5992.

    Article  CAS  PubMed  Google Scholar 

  6. Broglio F, Gottero C, Prodam F, et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004, 89: 3062–5.

    Article  CAS  PubMed  Google Scholar 

  7. Gauna C, Meyler FM, Janssen JA, et al. Administration of acylated ghrelin reduces insulin sensivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensivity. J Clin Endocrinol Metab 2004, 89: 5035–42.

    Article  CAS  PubMed  Google Scholar 

  8. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908–13.

    Article  PubMed  Google Scholar 

  9. Rigault C, Le Borgne F, Georges B, Demarquoy J. Ghrelin reduces hepatic mitochondrial fatty acid β oxidation. J Endocrinol Invest 2007, 30: RC4–8.

    CAS  PubMed  Google Scholar 

  10. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707–9.

    Article  PubMed  Google Scholar 

  11. Nedvídková J, Krykorková I, Barták V, et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2003, 88: 1678–82.

    Article  PubMed  Google Scholar 

  12. Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002, 56: 203–6.

    Article  CAS  Google Scholar 

  13. Silva JE. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 2003, 139: 205–13.

    Article  CAS  PubMed  Google Scholar 

  14. Riis AL, Hansen TK, Møller N, Weeke J, Jørgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003, 88: 853–7.

    Article  CAS  PubMed  Google Scholar 

  15. Giménez-Palop O, Giménez-Perez G, Mauricio D, et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol 2005, 153: 73–9.

    Article  PubMed  Google Scholar 

  16. Altinova AE, Toruner F, Karakoc A, et al. Serum Ghrelin Levels in patients with Hashimoto’s thyroiditis. Thyroid 2006, 16: 1259–64.

    Article  CAS  PubMed  Google Scholar 

  17. Altinova AE, Törüner FB, Aktürk M, et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res 2006, 65: 295–9.

    Article  CAS  PubMed  Google Scholar 

  18. Manuchehri AM, Sathyapalan T, Jayagopal V, et al. Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations. Clin Endocrinol (Oxf) 2008, 68: 836–8.

    Article  Google Scholar 

  19. Röjdmark S, Calissendorff J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves’ thyrotoxicosis before, during and after long-term pharmacological treatment. Endocrine 2005, 27: 55–61.

    Article  PubMed  Google Scholar 

  20. Gjedde S, Vestergaard ET, Gormsen LC, et al. Serum Ghrelin levels are increased in hypothyroid patients and became normalized by L-thyroxine treatment. J Clin Endocrinol Metab 2008, 93: 2277–80.

    Article  CAS  PubMed  Google Scholar 

  21. Campana D, Nori F, Pagotto U, et al. Plasma acylated gherlin levels are higher in patients with chronic atrophic gastritis. Clin Endocrinol (Oxf) 2007, 67: 761–6.

    Article  CAS  Google Scholar 

  22. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol 2002, 147: 159–63.

    Article  CAS  PubMed  Google Scholar 

  23. Seoane LM, Al-Massadi O, Barreiro F, Dieguez C, Casanueva FF. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J Endocrinol Invest 2007, 30: RC22–5.

    CAS  PubMed  Google Scholar 

  24. Saad MF, Bernaba B, Hwu, CM et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002, 87: 3997–4000.

    Article  CAS  PubMed  Google Scholar 

  25. Katsuki A, Urakawa H, Gabazza EC, et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004, 151: 573–7.

    Article  CAS  PubMed  Google Scholar 

  26. Kempa A, Krzyzanowska-Swiniarska B, Miazgowski T, Pilarska K. Not insulin but insulin sensivity, leptin and cortisol are major factors regulating serum acylated ghrelin level in healthy women. J Endocrinol Invest 2007, 30: 659–65.

    Article  CAS  PubMed  Google Scholar 

  27. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin. Diabetes 2003, 52: 16–20.

    Article  CAS  PubMed  Google Scholar 

  28. Caixás A, Bashore C, Nash W, Pi-Sunyer F, Laferrère B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002, 87: 1902–6.

    Article  PubMed  Google Scholar 

  29. Serra-Prat M, Fernández X, Burdoy E, et al; Mataró Ageing Study Group. The role of ghrelin in the energy homeostasis of elderly people: a population-based study. J Endocrinol Invest 2007, 30: 484–90.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Division of Endocrinology, V.le Borri 57, 21100, Varese, Italy

    M. L. Tanda, V. Lombardi, A. Lai, M. Gandolfo, I. Dalle Mule & L. Bartalena MD

  2. Division of Endocrinology, Department of Endocrinology and Metabolism, University of Pisa, Pisa

    M. Genovesi, F. Ultimieri, L. Grasso, F. Bogazzi, F. Broglio & E. Martino

  3. Division of Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy

    E. Ghigo

Authors
  1. M. L. Tanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Genovesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Ultimieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Gandolfo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Dalle Mule
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Grasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Bogazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Broglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E. Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. L. Bartalena MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Bartalena MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanda, M.L., Lombardi, V., Genovesi, M. et al. Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction. J Endocrinol Invest 32, 74–78 (2009). https://doi.org/10.1007/BF03345683

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345683

Key-words

Search

Navigation